Role of toxin functional domains in anthrax pathogenesis

Infection and Immunity

Volumn 68, Issue 4, 2000, Pages 1781-1786

  Brossier, Fabien ^a   Weber Levy, Martine ^a   Mock, Michele ^a   Sirard, Jean Claude ^a,b  

^a INSTITUT PASTEUR   (France)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ANTIBODY RESPONSE; ARTICLE; BACILLUS ANTHRACIS; FEMALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; TOXIN ANALYSIS;

ANIMALS; ANTHRAX; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; BLOTTING, WESTERN; EDEMA; FEMALE; LETHAL DOSE 50; MICE; MODELS, BIOLOGICAL; MUTAGENESIS, SITE-DIRECTED; PROTEIN STRUCTURE, TERTIARY; TIME FACTORS;

EID: 0034073579     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.4.1781-1786.2000     Document Type: Article

References (42)

1. Beall, F. A., M. J. Taylor, and C. B. Thorne. 1962. Rapid lethal effects in rats of a third component found upon fractionating the toxin of Bacillus anthracis. J. Bacteriol. 83:1274-1280.
2. Bragg, T. S., and D. L. Robertson. 1986. Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis. Gene 81:45-54.
3. Brossier, F., C. Guidi-Rontani, and M. Mock. 1998. Anthrax toxins. C. R. Soc. Biol. 192:437-444.
4. Brossier, F., J. C. Sirard, C. Guidi-Rontani, E. Duflot, and M. Mock. 1999. Functional analysis of the carhoxy-terminal domain of Bacillus anthracis protective antigen. Infect. Immun. 67:964-967.
5. Duesbery, N. S., C. P. Webb, S. H. Leppla, V. M. Gordon, K. R. Klimpel, T. D. Copeland, N. G. Ahn, M. K. Oskarsson, K. Fukasawa, K. D. Paull, and G. F. Vande woude. 1998. Proteolytic inactivation of map-kinase-kinase by anthrax lethal factor. Science 280:734-737.
6. Escuyer, V., E. Duflot, O. Sezer, A. Danchin, and M. Mock, 1988. Structural homology between virulence-associated bacterial adenylate cyclases. Gene 71:293-298.
7. Escuyer, V., and R. J. Collier. 1991. Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells. Infect. Immun. 59:3381-3386.
8. Ezzell, J. W., and T. G. Abshire. 1992. Serum protease cleavage of Bacillus anthracis protective antigen. J. Gen. Microbiol. 138:543-549.
9. Friedlander, A. M. 1986. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J. Biol. Chem. 261:7123-7126.
10. Guidi-Rontani, C., E. Duflot, and M. Mock. 1997. Anthrax lethal toxin-induced mitogenic response of human T-cells. FEMS Lett. 157:285-289.
11. Guidi-Rontani, C., M. Weber-Levy, E. Labruyere, and M. Mock. 1999. Germination of Bacillus anthracis within alveolar macrophages. Mol. Microbiol. 31:9-17.
12. Klimpel, K. R., S. S. Molloy, G. Thomas, and S. H. Leppla. 1992. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc. Natl. Acad. Sci. USA 89:10277-10281.
13. Klimpel, K. R., N. Arora, and S. H. Leppla. 1994. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol. Microbiol. 13:1093-1100.
14. Labruyère, E., M. Mock, W. K. Surewick, H. H. Mantsch, T. Rose, H. Munier, R. S. Sarfati, and O. Barzu. 1991. Structural and ligand-binding properties of a truncated form of Bacillus anthracis adenylate cyclase and of a catalytically inactive variant in which glutamine substitutes for lysine-346. Biochemistry 30:2619-2624.
15. Leppla, S. H. 1982. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations in eukaryotic cells. Proc. Natl. Acad. Sci. USA 79:3162-3166.
16. Leppla, S. H. 1988. Production and purification of anthrax toxin. Methods Enzymol. 165:103-116.
17. Little, S. F., J. M. Novak, J. R. Lowe, S. H. Leppla, Y. Singh, K. R. Klimpel, B. C. Lidgerding, and A. M. Friedlander. 1996. Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies. Microbiology 142:707-715.
18. Mikesell, P., B. E. Ivins, J. D. Ristroph, and T. M. Dreier. 1983. Evidence for plasmid-mediated toxin production in Bacillus anthracis. Infect. Immun. 39: 371-376.
19. Milne, J. C., and R. J. Collier. 1993. pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen. Mol. Microbiol. 10:647-653.
20. Milne, J. C., D. Furlong, P. C. Hanna, J. S. Wall, and R. J. Collier. 1994. Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J. Biol. Chem. 269:20607-20612.
21. Mock, M., E. Labruyère, P. Glaser, A. Danchin, and A. Ullmann. 1988. Cloning and expression of the calmodulin-sensitive Bacillus anthracis adenylate cyclase in Escherichia coli. Gene. 64:277-284.
22. Murphy, E., L. Huwyler, and C. M. de Freire Bastos. 1985. Transposon Tn544: complete nucleotide sequence and isolation of transposition-defective and antibiotic-sensitive mutants. EMBO J. 4:3357-3365.
23. Novak, J. M., M. P. Stein, S. F. Little, S. H. Leppla, and A. M. Friedlander. 1992. Functional characterization of protease-treated Bacillus anthracis protective antigen. J. Biol. Chem. 267:17186-17193.
24. Petosa, C., R. J. Collier, K. R. Klimpel, S. H. Leppla, and R. C. Liddington. 1997. Crystal structure of the anthrax toxin protective antigen. Nature 385: 833-838.
25. Pezard, C., P. Berche, and M. Mock. 1991. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 59:3472-3477.
26. Pezard, C., E. Duflot, and M. Mock. 1993. Construction of Bacillus anthracis mutant strains producing a single toxin component. J. Gen. Microbiol. 139: 2459-2463.
27. Pezard, C., M. Weber, J. C. Sirard, P. Berche, and M. Mock. 1995. Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect. Immun. 63:1369-1372.
28. Ristroph, J. D., and B. E. Ivins. 1983. Elaboration of Bacillus anthracis antigens in a new, defined culture medium. Infect. Immun. 39:483-486.
29. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
30. Singh, Y., V. K. Chaudhary, and S. H. Leppla. 1989. A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo. J. Biol. Chem. 264:19103-19107.
31. Singh, Y., K. R. Klimpel, C. P. Quinn, V. K. Chaudhary, and S. H. Leppla. 1991. The carboxyl-terminal end of protective antigen is required for receptor binding and anthrax toxin activity. J. Biol. Chem. 266:15493-15497.
32. Singh, Y., K. R. Klimpel, N. Arora, M. Sharma, and S. H. Leppla. 1994. The chymotrypsin-sensitive site, FFD(315), in anthrax toxin protective antigen is required for translocation of lethal factor. J. Biol. Chem. 269:29039-29046.
33. Stanley, J. L., and H. Smith. 1961. Purification of factor I and recognition of a third factor of anthrax toxin. J. Gen. Microbiol. 26:49-66.
34. Thomas, C. M., and C. A. Smith. 1987. Incompatibility group p pasmids: genetics, evolution, and use in genetic manipulation. Annu. Rev. Microbiol. 41:77-101.
35. Trieu-Cuot, P., and P. Courvalain. 1983. Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3′,5′-aminoglycoside phospho-transferase type III. Gene 23:331-341.
36. Trieu-Cuot, P., C. Carlier, C. Poyart-Salmeron, and P. Courvalin. 1990. Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545. Nucleic Acids Res. 18:3660.
37. Trieu-Cuot, P., C. Poyart-Salmeron, C. Carlier, and P. Courvalain. 1991. An integrative vector exploiting the transposition properties of Tn1545 for insertional mutagenesis and cloning genes from gram-positive bacteria. Gene 106:21-27.
38. Uchida, I., K. Hashimoto, and N. Terakado. 1986. Virulence and immunogenicity in experimental animals of Bacillus anthracis strains harbouring or lacking 110 MDa and 60 MDa plasmids. J. Gen. Microbiol. 132:557-559.
39. Varughese, M., A. V. Teixeira, S. Liu, and S. H. Leppla. 1999. Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin. Infect. Immun. 67:1860-1865.
40. Vitale, G., R. Pellizzari, C. Recchi, G. Napolitani, M. Mock, and C. Montecucco. 1998. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248:706-711.
41. Vodkin, M. H., and S. H. Leppla. 1983. Cloning of the protective antigen gene of Bacillus anthracis. Cell 34:693-697.
42. Xia, Z., and D. R. Storm. 1990. A-type ATP binding consensus sequences are critical for the catalytic activity of the calmodulin-sensitive adenylyl cyclase from Bacillus anthracis. J. Biol. Chem. 265:6517-6520.